Breast Cancer, Taxotere, Hair Loss & Schmitz

This entry was posted in Case Watch℠ Prescription Drug and tagged alopecia aventis baldness breast cancer california cancer chemotherapy chemptherapy hair loss mdl permanent hair loss sanofi sanofi-aventis taxol taxotere on by (updated 1437 days ago)

Breast Cancer, Taxotere, Hair Loss & Schmitz is a case about a woman that allegedly took the prescription drug taxotere for treatment of breast cancer and later suffered hair loss.

In the recent court order – in the California case, Breast Cancer, Taxotere, Hair Loss & Schmitz, the Court stayed the action pending the upcoming proceeding in the JPML.  The JPML proceeding concerns the formation of the an MDL for consolidation of the pending taxotere cases around the country and will be heard on September 29, 2016.

TAXOTERE

Recent information has surfaced that the intravenous chemotherapy breast cancer drug – Taxotere by Sanofi – may cause permanent hair loss (alopecia).  We all hope that when your doctor prescribes a drug to help you manage or overcome a health problem, you trust that it will be safe and effective. Unfortunately, that is not always the case. Sometimes, prescription drugs and other remedies can have serious side effects, including – like in Taxotere’s use for breast cancer – possible permanent hair loss.

Sometimes, the problem in connection with a prescription drugs is that the drug label does not have sufficient information on the label about these side effects (e.g., failure to warn) and, therefore, has not been passed on to the person using the prescription drug.

For one particular drug on the market, Taxotere (docetaxel, chemotherapy, taxol), manufactured by Sanofi (French company – also is the manufacturer of some of the generic taxotere drugs and Aventis, Sanofi-Aventis), it appears that there has been some recent information that Taxotere may be associated with permanent hair loss. The recent information relates to women:

  • that suffer from breast cancer
  • that have been treated with Taxotere (intravenously) and
  • that may have suffered an injury – permanent hair loss (baldness).

It also appears that the label for Taxotere (taxol) was updated recently – January 2016. To view the label summary, please follow this link – Taxotere and Hair Loss

The Gooch Law Firm is ready to represent individuals that may have used Taxotere for treatment of breast cancer and have suffered permanent hair loss or permanent significant alopecia (PSA).

We are currently investigating cases involving the use of Taxotere for breast cancer and later suffered permanent hair loss or alopecia.

FREE CASE REVIEWContact Us

At the Gooch Law Firm, we pride ourselves on providing our clients reliable representation for even the most challenging cases.

If you or someone you love has breast cancer, was administered or taken Taxotere or a taxotere generic (manufactured by Sanofi) and suffered permanent hair loss in connection with the use of Taxotere, please contact our office at 1.844.329.5955.

WE ARE HERE TO HELP YOU PROTECT YOUR LEGAL RIGHTS